This study identified that patients are not engaged in discussions or decisions about implantable medical devices.

Gagliardi, A. R., Lehoux, P., Ducey, A., Easty, A., Ross, S., Bell, C. M., & Urbach, D. R. (2017). Factors constraining patient engagement in implantable medical device discussions and decisions: Interviews with physicians, International Journal for Quality in Health Care.

This chapter provides readers with clear guidance on the ways in which particular qualitative methods can help HTA practitioners to elicit patients’ perspectives, experiences and preferences.

Lehoux, P., Jimenez-Pernett, J., (2017). Making sense of patients’ perspectives, experiences and preferences in HTA (pp.215-224). In Facey, K., Hensen, H.P., Single, A.N.V. (Eds). Patient Involvement in Health Technology Assessment (HTA). Singapore: Springer.

The goal of this paper is to clarify how entrepreneurs, investors, and regulatory agencies influence the value of emerging health technologies.

Lehoux, P., Miller, F.A., Daudelin, G., Denis, J.L. (2017). Providing value to new health technology: the early contribution of entrepreneurs, investors, and regulatory agencies, International Journal of Health Policy and Management.

This article seeks to deepen our understanding of the responsible research and innovation (RRI) approach as it relates to health care systems, where the notion of responsibility is already deeply embedded.

Demers-Payette, O., Lehoux, P., Daudelin, G. (2016). Responsible research and innovation: a productive model for the future of medical innovation, Journal of Responsible Innovation.

This article aims to generate a better understanding of the historical Research & Development dynamics that have contributed to shape today’s medical innovation ecosystem.

Lehoux, P., Roncarolo, F., Rocha Oliveira, R., Silva, H.P. (2016). Medical innovation and the sustainability of health systems: A historical perspective on technological change in health, Health Services Management Research.

This article looks at a prospective method using multimedia material for public deliberations on health technology design.

Lehoux, P., Jimenez-Pernett, J., Miller, F. A., Williams-Jones, B. (2016). Assessment of a multimedia-based prospective method to support public deliberations on health technology design: participant survey findings and qualitative insights, BMC Health Services Research.

This paper brings forward why capital investors choose to invest in certain health technology-based ventures and not others, and how they influence the innovation process.

Lehoux, P., Miller, F.A., Daudelin, G., Urbach, D.R. (2015). How venture capitalists decide which new medical technologies come to exist, Science & Public Policy.

This paper clarifies why technology developers are pushed to prioritize design features that expedite sales, often to the detriment of design features that would increase the clinical value of their technology.

Lehoux & al. (2014). How do business models and health technology design influence each other? Insights from a longitudinal case study of three academic spin-offs, Research Policy.

This book explains how health technology is embedded in broader social and political practices that can be reshaped through appropriate policy initiatives. It was short-listed along 3 others for the 2007 Best Book Award of the British Sociology Association and Sociology of Health & Illness.

Lehoux. P. (2006). The problem of health technology. Policy implications for modern health care systems. New York: Routledge.